Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Angiogenic Cell Therapy for Progressive Pulmonary Hypertension: Intervention With Repeat Dosing of eNOS-enhanced EPCs

NCT03001414 is registered in ClinicalTrials.gov with Northern Therapeutics as lead sponsor.

NCT NCT03001414
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03001414 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Angiogenic Cell Therapy for Progressive Pulmonary Hypertension: Intervention With Repeat Dosing of eNOS-enhanced EPCs
Lead sponsor
Northern Therapeutics
Phase
Phase 2/3
Overall status
Terminated
Start date
September 28, 2017
Completion date
November 1, 2023
Enrollment
22 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension,pulmonary